Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Nov 19;23(1):416.
doi: 10.1186/s12933-024-02482-x.

Hemodialysis dose and frequency should be considered in subgroup analysis

Lu Hu  1   2 , Zhonghua Wang  1 , Xiang He  3
Affiliations
Comment

Hemodialysis dose and frequency should be considered in subgroup analysis

Lu Hu et al. Cardiovasc Diabetol. .

Abstract

The article by Wang et al. titled "Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis" demonstrated that new SGLT-2i use in T2DM patients at the onset of dialysis was associated with a reduced long-term risk of all-cause mortality and MACE over a median follow-up duration of 2.0 years. However, the hemodialysis dose and frequency, which are significant confounding factors, were not included in the study's subgroup analysis. We raise concerns about this limitation, which may affect the study's findings.

PubMed Disclaimer

Conflict of interest statement

Declarations Ethics approval and consent to participate Not applicable. Competing interests The authors declare no competing interests.

Comment on

References

    1. Wang CA, Lin LC, Chen JY, Wang WJ, Wu VC. Exploring the mortality and cardiovascular outcomes with SGLT-2 inhibitors in patients with T2DM at dialysis commencement: a health global federated network analysis. Cardiovasc Diabetol. 2024;23(1):327. - PMC - PubMed
    1. Ashby D, Borman N, Burton J, Corbett R, Davenport A, Farrington K, Flowers K, Fotheringham J, Andrea Fox RN, Franklin G, et al. Renal association clinical practice guideline on haemodialysis. BMC Nephrol. 2019;20(1):379. - PMC - PubMed
    1. Liu SX, Wang ZH, Zhang S, Xiao J, You LL, Zhang Y, Dong C, Wang XN, Wang ZZ, Wang SN, et al. The association between dose of hemodialysis and patients mortality in a prospective cohort study. Sci Rep. 2022;12(1):13708. - PMC - PubMed
    1. Béguin L, Krummel T, Longlune N, Galland R, Couchoud C, Hannedouche T. Dialysis dose and mortality in haemodialysis: Is higher better? Nephrol Dial Transplant. 2021;36(12):2300–7. - PubMed
    1. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int. 2006;69(7):1222–8. - PubMed

MeSH terms

Substances

LinkOut - more resources